Visugromab

• CAT Number: I040859
• CAS Number: 2556646-63-8
• Purity: ≥95%

Visugromab(CAT: I040859) is a monoclonal antibody targeting growth differentiation factor-15 (GDF-15), a key regulator in immune suppression and tumor progression. By inhibiting GDF-15, Visugromab restores immune cell function, enhancing anti-tumor responses and improving immune surveillance. It is being investigated for its potential in cancer immunotherapy, particularly in combination with immune checkpoint inhibitors to overcome resistance mechanisms. With its innovative mechanism, Visugromab holds promise for enhancing the efficacy of cancer treatments, making it a valuable candidate for oncology research and the development of next-generation immunotherapeutic strategies.